SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study

/PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine,...

Related Keywords

Boston ,Massachusetts ,United States ,Switzerland ,America , ,Research Use ,Twitter ,North America ,Philippe Menu ,Chief Medical Officer ,Data Driven Medicine ,Research Use Only ,Sophia Genetics ,